CBD Market

Sir Ian Botham OBE partners with sports CBD brand

Botham has teamed up with EthicaCBD.

Sir Ian Botham OBE partners with sports CBD brand
Home / Sir Ian Botham OBE partners with sports CBD brand

CBD brand, EthicaCBD has announced its partnership between its Sports Gel and sporting legend Sir Ian Botham OBE.

Over a 15-year test cricket career and nearly four decades of global charity walks raising over £30 million, Sir Ian Botham OBE has pushed his body to the limits leading to decades of treatment and intense surgeries. 

Last Summer, six months prior to his recent knee surgery and at his least mobile, Sir Ian was introduced by his son Liam to a CBD sports gel that helped him return to his active lifestyle within a matter of weeks.

Read more: Clever Leaves to wind down Portugal operations

With plans this year to play golf tournaments and with a busy fundraising schedule that will have Sir Ian physically pushing himself, using the therapeutic gel is part of his daily routine.

Ian’s son, Liam Botham commented: “I sent the gel over to dad and three weeks later he was walking round Sunningdale.”

Ian was back on his feet walking round Sunningdale Golf Course after three weeks and after two months made a return to the Dunhill Links, playing three rounds of competitive golf despite not being able to make it round a course for at least two years prior to finding the gel.

Speaking on the Dunhill, about his experience using the therapeutic gel, Sir Ian said: “To get me through the Dunhill, I used the Gel 2-3 times per day. To be quite frank, without the gel, I wouldn’t have gotten round. This gel gives me the opportunity to get active again, quicker.”

The core ingredients of the sports gel are two cannabinoids – CBD and CBG. The most common topical application of these two legal cannabinoids (CBD and CBG) is for pain relief. The gel is made with 100% natural ingredients.

Lord Botham commented: “Sometimes you can do all the talking in the world, but when it actually comes to it, it’s gotta work, and it works.”

Topicscannabis industrycbdCBD products

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · CBD Market

CBD Brand Director Sentenced for Covid Loan Fraud and Money Laundering

Ben Stevens · 28 July 2026

More